Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets |
---|---|---|---|---|
Capital Group Central Cash Fund | Short Term | 12,284,657 | $1,228,342,834.00 | 6.43% |
Diebold Nixdorf, Inc., Term Loan, (3-month USD CME Term SOFR + 7.50%) 12.86% 10/2/2028 | Fixed Income | 200,419,290 | $206,682,393.00 | 1.08% |
Rotech Healthcare, Inc. | Equity | 1,916,276 | $201,208,980.00 | 1.05% |
NGL Energy Operating, LLC 7.50% 2/1/2026 | Fixed Income | 167,969,000 | $169,782,897.00 | 0.89% |
Diebold Nixdorf, Inc. | Equity | 5,800,284 | $167,918,222.00 | 0.88% |
FXI Holdings, Inc. 12.25% 11/15/2026 | Fixed Income | 183,755,000 | $164,003,359.00 | 0.86% |
DISH DBS Corp. 5.875% 11/15/2024 | Fixed Income | 155,330,000 | $145,784,661.00 | 0.76% |
DISH Network Corp. 11.75% 11/15/2027 | Fixed Income | 123,895,000 | $129,429,637.00 | 0.68% |
First Quantum Minerals, Ltd. 6.875% 10/15/2027 | Fixed Income | 141,362,000 | $120,334,403.00 | 0.63% |
FXI Holdings, Inc. 12.25% 11/15/2026 | Fixed Income | 127,259,000 | $114,214,953.00 | 0.6% |
Talen Energy Corp. | Equity | 1,794,464 | $114,845,696.00 | 0.6% |
New Fortress Energy, Inc. 6.50% 9/30/2026 | Fixed Income | 112,673,000 | $108,313,456.00 | 0.57% |
Teva Pharmaceutical Finance Netherlands III BV 5.125% 5/9/2029 | Fixed Income | 112,086,000 | $107,167,778.00 | 0.56% |
Carnival Corp. 6.00% 5/1/2029 | Fixed Income | 102,574,000 | $98,775,787.00 | 0.52% |
LCM Investments Holdings II, LLC 4.875% 5/1/2029 | Fixed Income | 103,149,000 | $95,946,105.00 | 0.5% |